BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37962070)

  • 1. Heart failure with preserved ejection fraction risk is associated with prevalence and severity of obstructive sleep apnea.
    Connolly JE; Genuardi MV; Mora JI; Prenner SB
    J Clin Sleep Med; 2024 Mar; 20(3):381-387. PubMed ID: 37962070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Applicability of H
    Jia XY; Liu LX; Wang DW; Ma XW; Liu YM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):154-160. PubMed ID: 38686710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and Validity of the HFA-PEFF and H
    Ariyaratnam JP; Mishima RS; Kadhim K; Emami M; Fitzgerald JL; Thiyagarajah A; Dziano JK; Howie JO; Middeldorp ME; Sanders P; Elliott AD
    JACC Heart Fail; 2024 Jun; 12(6):1015-1025. PubMed ID: 38520461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of HFA-PEFF and H
    Faxen UL; Venkateshvaran A; Shah SJ; Lam CSP; Svedlund S; Saraste A; Beussink-Nelson L; Lagerstrom Fermer M; Gan LM; Hage C; Lund LH
    J Card Fail; 2021 Jul; 27(7):756-765. PubMed ID: 33647474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of pulmonary hypertension in obstructive sleep apnea and its relation to disease severity.
    Milligan I; Shaw AK; Leu R; Kanaan U; Michelfelder E
    J Clin Sleep Med; 2024 May; 20(5):675-680. PubMed ID: 38078676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community.
    Selvaraj S; Myhre PL; Vaduganathan M; Claggett BL; Matsushita K; Kitzman DW; Borlaug BA; Shah AM; Solomon SD
    JACC Heart Fail; 2020 Aug; 8(8):640-653. PubMed ID: 32535127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the H
    Tada A; Nagai T; Omote K; Iwano H; Tsujinaga S; Kamiya K; Konishi T; Sato T; Komoriyama H; Kobayashi Y; Takenaka S; Mizuguchi Y; Sato T; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Int J Cardiol; 2021 Nov; 342():43-48. PubMed ID: 34364907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation the value of H
    Wang Z; Fang J; Hong H
    Acta Cardiol; 2023 Sep; 78(7):790-795. PubMed ID: 37318053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Hwang IC; Cho GY; Choi HM; Yoon YE; Park JJ; Park JB; Park JH; Lee SP; Kim HK; Kim YJ
    J Card Fail; 2021 Feb; 27(2):198-207. PubMed ID: 33035685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of the MAGGIC Score, H
    Przewlocka-Kosmala M; Butler J; Donal E; Ponikowski P; Kosmala W
    J Am Soc Echocardiogr; 2022 Sep; 35(9):966-975. PubMed ID: 35605894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H
    Amanai S; Harada T; Kagami K; Yoshida K; Kato T; Wada N; Obokata M
    Sci Rep; 2022 Jan; 12(1):13. PubMed ID: 34996984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry.
    Mert GÖ; Özlek B; Özlek E; Zencirkiran Ağuş H; Tekinalp M; Kahraman S; Çil C; Çelik O; Başaran Ö; Doğan V; Kaya BC; Rencüzoğulları İ; Ösken A; Bekar L; Çakır MO; Çelik Y; Sancar KM; Sevinç S; Biteker M; Mert KU
    Anatol J Cardiol; 2023 Sep; 27(9):539-548. PubMed ID: 37655737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea.
    Reddy YNV; Kaye DM; Handoko ML; van de Bovenkamp AA; Tedford RJ; Keck C; Andersen MJ; Sharma K; Trivedi RK; Carter RE; Obokata M; Verbrugge FH; Redfield MM; Borlaug BA
    JAMA Cardiol; 2022 Sep; 7(9):891-899. PubMed ID: 35830183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
    Koch DG; Rockey DC; Litwin SS; Tedford RJ
    Dig Dis Sci; 2024 May; ():. PubMed ID: 38782854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAHOS Study: Efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome - A 3-month, multicenter, randomized controlled clinical trial.
    Xie L; Li S; Yu X; Wei Q; Yu F; Tong J
    Eur J Clin Pharmacol; 2024 May; 80(5):771-780. PubMed ID: 38386021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the HFA-PEFF and H
    Tomasoni D; Aimo A; Merlo M; Nardi M; Adamo M; Bellicini MG; Cani D; Franzini M; Khalil A; Pancaldi E; Panichella G; Porcari A; Rossi M; Vergaro G; Lombardi CM; Sinagra G; Rapezzi C; Emdin M; Metra M
    Eur J Heart Fail; 2022 Dec; 24(12):2374-2386. PubMed ID: 35855616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled prevalences of obstructive sleep apnea and heart failure: a systematic review and meta-analysis.
    Prechaporn W; Hantrakul P; Ngamjarus C; Sukeepaisarnjaroen W; Sawanyawisuth K; Khamsai S
    Heart Fail Rev; 2024 Jul; 29(4):811-826. PubMed ID: 38722388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic value of the H
    Ishizu K; Shirai S; Isotani A; Hayashi M; Tabata H; Ohno N; Kakumoto S; Ando K; Yashima F; Tada N; Yamawaki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38607328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical characteristics of sleep-disordered breathing in patients with heart failure of different left ventricular ejection fractions.
    Wang T; Yu FC; Wei Q; Chen L; Xu X; Ding N; Tong JY
    Sleep Breath; 2023 Mar; 27(1):245-253. PubMed ID: 35394577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial.
    Bradley TD; Logan AG; Lorenzi Filho G; Kimoff RJ; Durán Cantolla J; Arzt M; Redolfi S; Parati G; Kasai T; Dunlap ME; Delgado D; Yatsu S; Bertolami A; Pedrosa R; Tomlinson G; Marin Trigo JM; Tantucci C; Floras JS;
    Lancet Respir Med; 2024 Feb; 12(2):153-166. PubMed ID: 38142697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.